Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-14

Clinical Trial Update: Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma [Phase 3]

View source ↗

Summary

Phase III trial evaluating two brain conformational radiotherapy regimens in combination with chemotherapy for Glioblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Glioblastoma | Phase 3 | Status: TERMINATED